Steven M. Goldman

All filings by Steven M. Goldman on record concern Dova Pharmaceuticals Inc. Between 5 July 2017 and 12 November 2019, the trades on record add up to 18 filings.

The open-market record is one-sided, with 7 purchases worth €2.1M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 8 option exercises.

The median purchase comes to €211k. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 12 November 2019, reports a transaction in Dova Pharmaceuticals Inc. The last purchase on record was published on 25 June 2018, which is 3,039 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.